Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA complex group 9 pseudogene 5 (HCG9P5) is a human pseudogene within the major histocompatibility complex (MHC), also annotated as HCGIX-5 or dJ377H14.6[1][2][4]. It does not produce a functional protein, and its precise biological role, if any, remains unknown; some studies have examined the methylation status of the broader HLA complex group 9 region in psychiatric disease, but HCG9P5 itself is not established as a functional or therapeutic target[1][2][3][4][5]. It is not used in drug targeting, biomarker development, or clinical safety evaluation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA complex group 9 pseudogene 5 (HCG9P5).